Guizhou Bailing Group Pharmaceutical Management
Management criteria checks 4/4
Guizhou Bailing Group Pharmaceutical's CEO is Min Niu, appointed in Apr 2015, has a tenure of 9.67 years. directly owns 0.02% of the company’s shares, worth CN¥1.01M. The average tenure of the management team and the board of directors is 9.7 years and 4.6 years respectively.
Key information
Min Niu
Chief executive officer
CN¥720.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.7yrs |
| CEO ownership | 0.02% |
| Management average tenure | 9.7yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise
Nov 13
Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?
Oct 24Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S
Aug 15Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 10CEO
Min Niu (54 yo)
9.7yrs
Tenure
CN¥720,000
Compensation
Mr. Min Niu serves as a Director of Guizhou Bailing Group Pharmaceutical Co.,Ltd. from December 25, 2007 and serves as its General Manager and Secretary since April 02, 2015. He served as Deputy General Ma...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, Secretary & Director | 9.7yrs | CN¥720.00k | 0.020% CN¥ 1.0m | |
| Chief Financial Officer | 4yrs | CN¥480.00k | no data | |
| Deputy GM & Director | 11.8yrs | CN¥720.00k | 0.017% CN¥ 851.8k | |
| Director | no data | CN¥720.00k | no data |
9.7yrs
Average Tenure
46.5yo
Average Age
Experienced Management: 002424's management team is seasoned and experienced (9.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, Secretary & Director | 17yrs | CN¥720.00k | 0.020% CN¥ 1.0m | |
| Deputy GM & Director | 11.8yrs | CN¥720.00k | 0.017% CN¥ 851.8k | |
| Director | 17yrs | CN¥720.00k | no data | |
| Chairman | 17yrs | no data | 17.97% CN¥ 915.1m | |
| Member of the Supervisory Board | 10.9yrs | no data | no data | |
| Shareholder Supervisor | 4.6yrs | no data | no data | |
| Independent Director | 4.6yrs | CN¥60.00k | no data | |
| Shareholder Supervisor | 1.5yrs | no data | no data | |
| Director | 2.8yrs | CN¥720.00k | no data | |
| Independent Director | 1.5yrs | CN¥35.00k | no data | |
| Independent Director | 1.5yrs | CN¥35.00k | no data | |
| Chairman of Supervisory Board | 1.5yrs | no data | no data |
4.6yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 002424's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 18:14 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guizhou Bailing Group Pharmaceutical Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Yaming Liu | Founder Securities Co., Ltd. |
| Weina Sun | Shenwan Hongyuan Securities |